Sickle Cell Disease
JAMA Clinical Reviews
00:00
Three New Treatments for Sickle Cell Disease
There have been three additional therabies of roof for sickle cell, alglutomine, chrysalisma and boxellator. Chryalisab is a monoclonal antibody that's directed at p selecton, which is an adhesion molecule on activated plateless and andithelial cells. Sovoxaltor is still early in the understanding of its benefits but it significantly increases hemoglobin in individuals. And vocelator is the latest addition to the armamtarium. It stabilizes hemoglobin by promoting the binding of oxygen to hemoglobin s.
Transcript
Play full episode
